title: [Microbiological and epidemiological evaluation of carbapenem-resistant Acinetobacter baumannii clones isolated at an intensive care unit of a University Hospital in Buenos Aires city].
abstract: From June to December 2004, thirty-three carbapenem-resistant Acinetobacter baumannii isolates recovered from twenty nine patients at the intensive care unit in Hospital de Clínicas, Universidad de Buenos Aires, were studied. The isolates were categorized by molecular methods as: clone I (n = 14), clone IV (n = 7), clone III (n = 6), clone VI (n = 3), clone II (n = 2) and clone X (n = 1). Twenty one isolates were recovered from lower respiratory tract samples, 11 of which belonged to clone I. Clone III isolates were mainly recovered from non-respiratory samples (5/6). Clone IV isolates were recovered from patients not receiving previous imipenem therapy. The majority of the isolates belonging to clones I and IV were able to survive on inert materials for more than 5 days, whereas adhesion to catheters was observed in isolates belonging to clones I and III, especially in those related to bacteremia. Clone III isolates showed colistin, gentamicin and levofloxacin susceptibility, whereas clone I isolates and most from clone IV were only susceptible to colistin and tetracyclines.
authors.affiliation: Laboratorio de Bacteriología, Departamento de Bioquímica Clínica, Hospital de Clínicas, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires. Av. Córdoba 2351 (1120), Ciudad Autónoma de Buenos Aires, Argentina. carlos_hernanrodriguez@hotmail.com.ar
authors.forename: C H
authors.initials: CH
authors.lastname: Rodriguez
authors.forename: K
authors.initials: K
authors.lastname: Bombicino
authors.forename: G
authors.initials: G
authors.lastname: Granados
authors.forename: C
authors.initials: C
authors.lastname: Vay
authors.forename: A
authors.initials: A
authors.lastname: Famiglietti
mesh_terms: D000151:Acinetobacter Infections / Q000453:epidemiology / Q000382:microbiology*; D040981:Acinetobacter baumannii / Q000187:drug effects / Q000302:isolation & purification*; D000328:Adult; D001118:Argentina / Q000453:epidemiology; D001422:Bacterial Adhesion; D015780:Carbapenems / Q000494:pharmacology*; D055499:Catheter-Related Infections / Q000453:epidemiology / Q000382:microbiology; D002999:Clone Cells / Q000187:drug effects; D003428:Cross Infection / Q000453:epidemiology / Q000382:microbiology*; D004196:Disease Outbreaks; D004197:Disease Reservoirs; D024901:Drug Resistance, Multiple, Bacterial; D004866:Equipment Contamination; D006785:Hospitals, University; D006786:Hospitals, Urban; D006801:Humans; D007362:Intensive Care Units; D018410:Pneumonia, Bacterial / Q000453:epidemiology / Q000382:microbiology; D012121:Respiration, Artificial / Q000009:adverse effects / Q000295:instrumentation; D018440:beta-Lactam Resistance
chemical_list: D015780:Carbapenems